Skip to main content
2026 CRT Conference Main banner

CRT 2026

Coronary

Session:: ACS and AMI Management

Panel Discussion | Thrombus Management and Anticoagulation

Sunday, March 8, 2026
4:06 PM - 4:26 PM EST
Location: Lincoln

    Moderator(s)

  • Usman Baber, MD, MS

    Professor of Medicine
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma, United States

    Disclosure information not submitted.

  • David J. Cohen, MD, FSCAI

    Director of Clinical and Outcomes Research
    Cardiovascular Research Foundation
    New York, New York, United States

    Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

  • Luis Ortega-Paz, MD, PhD

    Assistant professor
    University of Florida College of Medicine-Jacksonville
    Jacksonville, Florida, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Dominick J. Angiolillo, MD, PhD, FSCAI

    Professor of Medicine
    University of Florida College of Medicine - Jacksonville
    Jacksonville, Florida, United States

    Disclosure(s): No financial relationships to disclose

  • SA

    Surendra Avula, MD, FACC

    Medical center Clinical Assocaite professor of medicine /Cardiology. University of illinois
    Advocate Christ medical center/ Palos North Western Medical center
    Orland park, Illinois, United States

    Disclosure(s): No financial relationships to disclose

  • Marc Cohen, MD

    Chair of Medicine
    Newark Beth Israel Med Ctr
    Philadelphia, Pennsylvania, United States

    Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)

  • C. Michael Gibson, MD

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure information not submitted.

  • Martine Gilard, MD,Phd

    Professor
    University of Brest
    Brest, France

    Disclosure(s): No financial relationships to disclose

  • Paul A. Gurbel, MD, FSCAI

    Director
    Sinai Center for Thrombosis Research and Drug Development
    Baltimore, Maryland, United States

    Disclosure information not submitted.

Disclosure(s):
David J. Cohen, MD, FSCAI: Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Dominick J. Angiolillo, MD, PhD, FSCAI: No financial relationships to disclose
Surendra Avula, MD, FACC: No financial relationships to disclose
Marc Cohen, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Ongoing)
Martine Gilard, MD,Phd: No financial relationships to disclose